Adam H. Zaeske - CHIEF COMMERCIAL OFFICER at Harmony Biosciences Holdings, Inc.

Issuer-level insider activity

Role: Chief Commercial Officer
Issuer ticker: HRMY on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Adam H. Zaeske since 06 Oct 2025

Reported holdings for Adam H. Zaeske in Harmony Biosciences Holdings, Inc.

Form 4 holding CHIEF COMMERCIAL OFFICER

Harmony Biosciences Holdings, Inc.

Security class: Restricted Stock Units
Shares / value: 7,500
Estimated value: $993,456
Report date: 07 Apr 2026
Price: $33.12
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding CHIEF COMMERCIAL OFFICER

Harmony Biosciences Holdings, Inc.

Security class: Common Stock
Shares / value: 4,327
Estimated value: $121,197
Report date: 07 Apr 2026
Price: $28.01
Ownership: Direct

Form 4 holding CHIEF COMMERCIAL OFFICER

Harmony Biosciences Holdings, Inc.

Security class: Stock Option
Shares / value: 56,900
Estimated value
Report date: 22 Jan 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for Adam H. Zaeske in Harmony Biosciences Holdings, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .